Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

13.07
-0.5400-3.97%
Post-market: 13.100.0300+0.23%19:21 EDT
Volume:5.65M
Turnover:74.01M
Market Cap:1.29B
PE:-2.24
High:13.59
Open:13.56
Low:12.88
Close:13.61
52wk High:39.89
52wk Low:12.88
Shares:98.32M
Float Shares:80.72M
Volume Ratio:1.21
T/O Rate:7.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-4.42
PE(LYR):-2.24

Loading ...

Ultragenyx treatment of GNE myopathy granted orphan designation

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 08

Ultragenyx price target lowered to $32 from $43 at Barclays

TIPRANKS
·
Sep 04

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live
·
Sep 04

Nvidia, Tesla, Robinhood, Snowflake, Ultragenyx, Ciena, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 04

Ultragenyx downgraded to Equal Weight from Overweight at Morgan Stanley

TIPRANKS
·
Sep 04

Ultragenyx falls -44.0%

TIPRANKS
·
Sep 04

Ultragenyx Pharmaceutical Down over 45%, on Pace for Record Low Close and Record Percent Decrease

Dow Jones
·
Sep 03

Ultragenyx Hits Record Low After Rare Disease Drug Trial Failure

Reuters
·
Sep 03

Why Is Ultragenyx Pharmaceutical Stock (RARE) Down Today?

TIPRANKS
·
Sep 03

U.S. Stocks on the MOVE-Gold Miners, Polestar Automotive, Nvidia

Reuters
·
Sep 03

Ultragenyx price target lowered to $28 from $77 at Jefferies

TIPRANKS
·
Sep 03

Wedbush Keeps Their Hold Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 03

Ultragenyx price target lowered to $33 from $103 at Cantor Fitzgerald

TIPRANKS
·
Sep 03

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)

TIPRANKS
·
Sep 03

Ultragenyx Stock Sinks 47% on Drug Trial Failure. Why Wall Street Isn't Giving up Yet.

Dow Jones
·
Sep 03

U.S. Stocks on the MOVE-Snowflake, Ultragenyx Pharmaceutical, Broadcom

Reuters
·
Sep 03

Top Premarket Decliners

MT Newswires Live
·
Sep 03

Wedbush Adjusts Price Target on Ultragenyx Pharmaceutical to $23 From $30, Maintains Neutral Rating

MT Newswires Live
·
Sep 03

Canaccord Genuity Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 03